Literature DB >> 11780970

Cancer proteomics: from signaling networks to tumor markers.

R J Simpson1, D S Dorow.   

Abstract

Along with the great strides that have been made towards understanding cancer, has come a realization of the complexity of molecular events that lead to malignancy. Proteomics-based approaches, which enable the quantitative investigation of both cellular protein expression levels and protein-protein interactions involved in signaling networks, promise to define the molecules controlling the processes involved in cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11780970     DOI: 10.1016/S0167-7799(01)01801-7

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  17 in total

Review 1.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

2.  Stamping vital cells - a force-based ligand receptor assay.

Authors:  Uta Wienken; Hermann E Gaub
Journal:  Biophys J       Date:  2013-12-17       Impact factor: 4.033

3.  Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas.

Authors:  Okay Saydam; Ozlem Senol; Tieneke B M Schaaij-Visser; Thang V Pham; Sander R Piersma; Anat O Stemmer-Rachamimov; Thomas Wurdinger; Saskia M Peerdeman; Connie R Jimenez
Journal:  J Proteome Res       Date:  2010-01       Impact factor: 4.466

4.  Different expression of S100A8 in malignant and benign gallbladder diseases.

Authors:  Wei Wang; Kai-Xing Ai; Zhou Yuan; Xin-Yu Huang; Hui-Zhen Zhang
Journal:  Dig Dis Sci       Date:  2012-07-18       Impact factor: 3.199

5.  Comparative analyses of differentially induced T-cell receptor-mediated phosphorylation pathways in T lymphoma cells.

Authors:  Serina Ortiz; Wenhui Lee; David Smith; Stephen J Forman; Terry D Lee; Chih-Pin Liu
Journal:  Exp Biol Med (Maywood)       Date:  2010-12

6.  Intact mass detection, interpretation, and visualization to automate Top-Down proteomics on a large scale.

Authors:  Kenneth R Durbin; John C Tran; Leonid Zamdborg; Steve M M Sweet; Adam D Catherman; Ji Eun Lee; Mingxi Li; John F Kellie; Neil L Kelleher
Journal:  Proteomics       Date:  2010-10       Impact factor: 3.984

Review 7.  Moving forward in colorectal cancer research, what proteomics has to tell.

Authors:  Nerea Bitarte; Eva Bandrés; Ruth Zárate; Natalia Ramirez; Jesus Garcia-Foncillas
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

8.  Down-regulation of SM22/transgelin gene expression during H9c2 cells differentiation.

Authors:  Elisa Bregant; Giovanni Renzone; Renata Lonigro; Nadia Passon; Carla Di Loreto; Maura Pandolfi; Andrea Scaloni; Gianluca Tell; Giuseppe Damante
Journal:  Mol Cell Biochem       Date:  2009-02-18       Impact factor: 3.396

9.  Array-based sensing of metastatic cells and tissues using nanoparticle-fluorescent protein conjugates.

Authors:  Subinoy Rana; Arvind K Singla; Avinash Bajaj; S Gokhan Elci; Oscar R Miranda; Rubul Mout; Bo Yan; Frank R Jirik; Vincent M Rotello
Journal:  ACS Nano       Date:  2012-09-04       Impact factor: 15.881

10.  Proteomics in melanoma biomarker discovery: great potential, many obstacles.

Authors:  Michael S Sabel; Yashu Liu; David M Lubman
Journal:  Int J Proteomics       Date:  2011-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.